[1]Patent:WO2016/123253,2016,A1.Locationinpatent:Page/Pagecolumn34
1461713-91-6 | 2-[5-(propan-2-yl)-1,2,4-oxadiazol-3-yl]azepane hydrochloride | AA01A6YX | MFCD25970508
1016767-16-0 | N'-hydroxy-3-(morpholin-4-ylmethyl)benzene-1-carboximidamide | AA01A7G1 | MFCD09933459
1221726-29-9 | 2-[(4-Methoxyphenyl)methoxy]pyridine-4-carboximidamide hydrochloride | AA01A7KM | MFCD14705741
640766-50-3 | N-methyl-2-phenoxyaniline | AA01A7PA | MFCD11151225
1251924-17-0 | 2-Amino-3-[4-(methylsulfanyl)phenyl]propanoic acid hydrochloride | AA01A7TV | MFCD14705859
405058-06-2 | N-methyl-1-(pyridin-2-yl)piperidin-4-amine | AA01A7XX | MFCD12048853
1240526-79-7 | 1,4-difluoro-2-trifluoromethanesulfonylbenzene | AA01A83A | MFCD16622025
153783-86-9 | 2-{[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl}acetic acid | AA01A87D | MFCD04067646
1018612-02-6 | 2-(3-Bromophenyl)morpholine | AA01A8AO | MFCD10035261
1235439-86-7 | 3-(4-fluorophenyl)cyclobutane-1-carboxylic acid | AA01A8FP | MFCD16040068